首页> 外文期刊>Diabetes research and clinical practice >A report on the diagnosis of intermediate hyperglycemia in Korea: A pooled analysis of four community-based cohort studies.
【24h】

A report on the diagnosis of intermediate hyperglycemia in Korea: A pooled analysis of four community-based cohort studies.

机译:韩国中间高血糖诊断报告:四个社区队列研究的汇总分析。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Many studies show poor agreement between fasting plasma glucose (FPG)-based and 2-h postchallenge glucose (2-h PG)-based criteria to assess glucose metabolism. We examined the rate of agreement between FPG- and 2-h PG-based criteria in the diagnosis of intermediate hyperglycemia in four representative cohort studies in South Korea and compared the clinical characteristics and biochemical parameters in subjects with impaired fasting glucose (IFG) according to their FPG values. Of 6234 subjects from four population-based studies performed from 1993 to 2000, 4610 individuals with data from a 75g oral glucose tolerance test (OGTT) and no previous history of diabetes were selected. We examined the concordance rate between the FPG and 2-h PG-based criteria. We also investigated the differences in the clinical characteristics and biochemical parameters between individuals with IFG according to their FPG values. The fasting and 2-h PG criteria had large discordance rates in the diagnosis of diabetes and impaired glucose tolerance (IGT) in Korean adults. When individuals with IFG were classified into stage 1 [5.6-6.1mmol/L (100-109mg/dL)] and stage 2 [6.1-7.0mmol/L (110-125mg/dL)] IFG, individuals with stage 2 IFG are more obese and had higher blood pressure and total cholesterol and triglycerides concentrations compared with those with stage 1 IFG. In addition, more individuals with stage 2 IFG were with diabetes as determined by a 2-h PG>or=11.1mmol/L (14.1% vs. 1.9%) (P<0.05). Considering the poorer metabolic profile and higher percentage of people with diabetes by OGTT, these data indicate that, in the Korean population, individuals with stage 2 IFG should be treated differently from those with stage 1 IFG. To detect more cases of diabetes, the OGTT is recommended for all individuals with stage 2 IFG and cases with stage 1 IFG with some additional risk factors for diabetes.
机译:许多研究表明,基下的空腹葡萄糖(FPG)与2-H后葡萄糖(2-H PG)的基于标准评估葡萄糖代谢的标准之间的差。我们研究了基于FPG和2-H PG的标准在韩国四个代表队列研究中诊断基于FPG和2-H PG的标准的协议率,并将依照的临床特征和生物化学参数进行了抑制他们的FPG值。在1993年至2000年的四种基于人口的研究中,4610个个体的6234名受试者,其中4610个具有来自75g口服葡萄糖耐量试验(OGTT)的数据,并且选择了以前的糖尿病史。我们检查了FPG和基于2-H PG的标准之间的一致性速率。我们还根据其FPG值调查了IFG中个体之间临床特征和生化参数的差异。禁食和2-H PG标准在糖尿病诊断和韩国成年人的葡萄糖耐量(IGT)受损的情况下具有大的不良率。当具有IFG的个体被分类为第1阶段[5.6-6.1mmol / L(100-109mg / L)]和第2阶段[6.1-7.0mmol / L(110-125mg / dl)] IFG,具有阶段2的IFG是与阶段1 IFG的人相比,更多肥胖和血压和总胆固醇和甘油三酯浓度。此外,具有阶段2 IFG的更多个体是糖尿病,如2-H pg>或= 11.1mmol / L测定(14.1%vs.1.9%)(P <0.05)。考虑到OGTT糖尿病患者较差的代谢型材和较高百分比,这些数据表明,在韩国人口中,应与第1阶段IFG的人不同地对待有阶段2FG的个人。为了检测更多的糖尿病病例,建议ogtt用于阶段2 IFG和阶段1 IFG的病例,具有一些额外的糖尿病风险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号